With the conclusion of Super Bowl LX and the Seattle Seahawks' dominant victory over the New England Patriots comes the start of a new league year in the NFL as teams look to the offseason and the ...

Membrane compartments (vesicles) were prepared from two phospholipids with distinct acyl-chain structures, each encapsulating a different DNA species. Upon repeated freeze–thaw (F/T) cycles, the ...

The full 12-team playoff was revealed Sunday, with the top four seeds earning first-round byes, and eight teams scheduled to play in the first-round at campus sites. We wrap up the first round of the ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

On Tuesday, Nov. 11, shortly after the College Football Playoff selection committee revealed its latest top 25 rankings, playoff committee chairman Mack Rhoades sat down with ESPN to discuss why teams ...

An Obsidian plugin to expand your editor selection to lines, sections (recursive), or the entire note. This plugin is primarily designed for mobile convenience. "Expand to Section" is useful on ...

Listen up! Netflix is officially diving into the podcast biz: The video-streaming giant inked a deal with Spotify to bring a batch of top original podcasts, including from Bill Simmons’ The Ringer, to ...

If you are looking to micro-manage your folders in Outlook, it is essential to organize them. You can alphabetically sort out the folders to make navigation quicker and more intuitive, especially when ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...

The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. This was largely due to news from a ...

Shares of Recursion Pharmaceuticals (NASDAQ:RXRX) traded higher in the premarket on Tuesday after the AI-driven biotech announced plans to reduce its workforce by approximately 20% as part of a ...